117 related articles for article (PubMed ID: 38873854)
1. Strategies to enhance nasopharyngeal carcinoma screening in patients with adult-onset idiopathic inflammatory myopathies.
Tang IYK; Li TWL; Luk LTH; Ho B; Ho R; Lai BTL; Lee PML; So H
Int J Rheum Dis; 2024 Jun; 27(6):e15215. PubMed ID: 38873854
[No Abstract] [Full Text] [Related]
2. Evaluation of circulating EBV microRNA BART2-5p in facilitating early detection and screening of nasopharyngeal carcinoma.
Jiang C; Chen J; Xie S; Zhang L; Xiang Y; Lung M; Kam NW; Kwong DL; Cao S; Guan XY
Int J Cancer; 2018 Dec; 143(12):3209-3217. PubMed ID: 29971780
[TBL] [Abstract][Full Text] [Related]
3. Multiparametric Detection of Antibodies against Different EBV Antigens to Predict Risk for Nasopharyngeal Carcinoma in a High-Risk Population of China.
Chen H; Chen S; Lu J; Wang X; Li J; Li L; Fu J; Scheper T; Meyer W; Peng YH; Liu W
Cancer Prev Res (Phila); 2017 Sep; 10(9):542-550. PubMed ID: 28754665
[TBL] [Abstract][Full Text] [Related]
4. Distinguishing early-stage nasopharyngeal carcinoma from benign hyperplasia using intravoxel incoherent motion diffusion-weighted MRI.
Ai QY; King AD; Chan JSM; Chen W; Chan KCA; Woo JKS; Zee BCY; Chan ATC; Poon DMC; Ma BBY; Hui EP; Ahuja AT; Vlantis AC; Yuan J
Eur Radiol; 2019 Oct; 29(10):5627-5634. PubMed ID: 30903340
[TBL] [Abstract][Full Text] [Related]
5. A comparison of EBV serology and serum cell-free DNA as screening tools for nasopharyngeal cancer: Results of the Singapore NPC screening cohort.
Tay JK; Siow CH; Goh HL; Lim CM; Hsu PP; Chan SH; Loh KS
Int J Cancer; 2020 May; 146(10):2923-2931. PubMed ID: 31705522
[TBL] [Abstract][Full Text] [Related]
6. Incidence and mortality of nasopharyngeal carcinoma: interim analysis of a cluster randomized controlled screening trial (PRO-NPC-001) in southern China.
Ji MF; Sheng W; Cheng WM; Ng MH; Wu BH; Yu X; Wei KR; Li FG; Lian SF; Wang PP; Quan W; Deng L; Li XH; Liu XD; Xie YL; Huang SJ; Ge SX; Huang SL; Liang XJ; He SM; Huang HW; Xia SL; Ng PS; Chen HL; Xie SH; Liu Q; Hong MH; Ma J; Yuan Y; Xia NS; Zhang J; Cao SM
Ann Oncol; 2019 Oct; 30(10):1630-1637. PubMed ID: 31373615
[TBL] [Abstract][Full Text] [Related]
7. Polygenic risk-stratified screening for nasopharyngeal carcinoma in high-risk endemic areas of China: a cost-effectiveness study.
Yang DW; Miller JA; Xue WQ; Tang M; Lei L; Zheng Y; Diao H; Wang TM; Liao Y; Wu YX; Zheng XH; Zhou T; Li XZ; Zhang PF; Chen XY; Yu X; Li F; Ji M; Sun Y; He YQ; Jia WH
Front Public Health; 2024; 12():1375533. PubMed ID: 38756891
[TBL] [Abstract][Full Text] [Related]
8. Liu et al. respond to "Epstein-Barr virus screening for nasopharyngeal carcinoma".
Liu Z; Ye W; Zeng YX; Cao SM
Am J Epidemiol; 2013 Feb; 177(3):254-5. PubMed ID: 23255782
[No Abstract] [Full Text] [Related]
9. A novel and non-invasive approach utilising nasal washings for the detection of nasopharyngeal carcinoma.
Tan GW; Sivanesan VM; Abdul Rahman FI; Hassan F; Hasbullah HH; Ng CC; Khoo AS; Tan LP
Int J Cancer; 2019 Oct; 145(8):2260-2266. PubMed ID: 30698824
[TBL] [Abstract][Full Text] [Related]
10. Early detection of nasopharyngeal carcinoma: performance of a short contrast-free screening magnetic resonance imaging.
King AD; Ai QYH; Lam WKJ; Tse IOL; So TY; Wong LM; Tsang JYM; Leung HS; Zee BCY; Hui EP; Ma BBY; Vlantis AC; van Hasselt AC; Chan ATC; Woo JKS; Chan KCA
J Natl Cancer Inst; 2024 May; 116(5):665-672. PubMed ID: 38171488
[TBL] [Abstract][Full Text] [Related]
11. Nasopharyngeal Epstein-Barr Virus Load: An Efficient Supplementary Method for Population-Based Nasopharyngeal Carcinoma Screening.
Chen Y; Zhao W; Lin L; Xiao X; Zhou X; Ming H; Huang T; Liao J; Li Y; Zeng X; Huang G; Ye W; Zhang Z
PLoS One; 2015; 10(7):e0132669. PubMed ID: 26151639
[TBL] [Abstract][Full Text] [Related]
12. Nasopharyngeal cancer screening with an anti-BNLF2b antibody: a new arrow in the quiver?
Lam WKJ; Chan ATC
Nat Rev Clin Oncol; 2024 Jan; 21(1):6-7. PubMed ID: 37794170
[No Abstract] [Full Text] [Related]
13. Recommendations for Epstein-Barr virus-based screening for nasopharyngeal cancer in high- and intermediate-risk regions.
Lam WKJ; King AD; Miller JA; Liu Z; Yu KJ; Chua MLK; Ma BBY; Chen MY; Pinsky BA; Lou PJ; Woo JKS; Hsu WL; Simon J; Doolan DL; Waterboer T; Hui EP; Li H; Tsang RK; Wong KCW; Goh JP; Vlantis AC; Ai QY; Wong LM; Abdullah V; Lin JC; Chen CJ; Pfeiffer RM; Le QT; Lee AWM; Ji M; Cao S; Ma J; Chan ATC; Chan KCA; Hildesheim A
J Natl Cancer Inst; 2023 Apr; 115(4):355-364. PubMed ID: 36723440
[TBL] [Abstract][Full Text] [Related]
14. Complementary roles of MRI and endoscopic examination in the early detection of nasopharyngeal carcinoma.
King AD; Woo JKS; Ai QY; Chan JSM; Lam WKJ; Tse IOL; Bhatia KS; Zee BCY; Hui EP; Ma BBY; Chiu RWK; van Hasselt AC; Chan ATC; Lo YMD; Chan KCA
Ann Oncol; 2019 Jun; 30(6):977-982. PubMed ID: 30912815
[TBL] [Abstract][Full Text] [Related]
15. Routine coagulation molecules predict nasopharyngeal carcinoma and associated metastases.
Yin J; Zhu SS
Br J Biomed Sci; 2019 Oct; 76(4):178-183. PubMed ID: 31210089
[No Abstract] [Full Text] [Related]
16. Risk Factors and Cancer Screening in Myositis.
Moghadam-Kia S; Oddis CV; Ascherman DP; Aggarwal R
Rheum Dis Clin North Am; 2020 Aug; 46(3):565-576. PubMed ID: 32631604
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Transnasal Endoscopic Fine-Needle Aspiration Biopsy in Diagnosing Submucosal Nasopharyngeal Carcinoma.
Tang QN; Tang LQ; Liu LT; Wen DX; Lu ZJ; Ou GP; Yan JJ; Yang JH; Li JB; Wen YF; Guo SS; Liu SL; Xie HJ; Sun XS; Li XY; Chen QY; Mai HQ
Laryngoscope; 2021 Aug; 131(8):1798-1804. PubMed ID: 33616259
[TBL] [Abstract][Full Text] [Related]
18. A comprehensive risk score for effective risk stratification and screening of nasopharyngeal carcinoma.
Zhou X; Cao SM; Cai YL; Zhang X; Zhang S; Feng GF; Chen Y; Feng QS; Chen Y; Chang ET; Liu Z; Adami HO; Liu J; Ye W; Zhang Z; Zeng YX; Xu M
Nat Commun; 2021 Aug; 12(1):5189. PubMed ID: 34465768
[TBL] [Abstract][Full Text] [Related]
19. Hopkins criteria for residual disease assessment after definitive radiotherapy in nasopharyngeal carcinoma.
Liu Y; Long W; Wang G; Yang Y; Liu B; Fan W
Cancer Med; 2020 Feb; 9(4):1328-1334. PubMed ID: 31875356
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Epstein-Barr Virus Serological Tools for the Screening and Risk Assessment of Nasopharyngeal Carcinoma: a Large Population-based Study.
Guo J; Cui Z; Zheng Y; Li X; Chen Y
Pathol Oncol Res; 2020 Oct; 26(4):2185-2190. PubMed ID: 32222897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
